Asymptomatic Flu Project
NCT02868658 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 289
Last updated 2025-12-19
Summary
Although clinical presentation of influenza is often symptomatic, asymptomatic cases also occur. The knowledge of the incidence of asymptomatic influenza among healthcare workers is very important because of the risk of cross-transmission to hospitalized patients. The principal objective of the study is to estimate the incidence of symptomatic and asymptomatic influenza among healthcare workers in short-stay wards. The results of this study will lead to a better understanding of the burden of asymptomatic influenza among healthcare workers and might be used as an argument to increase influenza vaccine coverage among healthcare workers.
Conditions
Interventions
- BIOLOGICAL
-
Blood sampling
- OTHER
-
Nasal swab
Sponsors & Collaborators
-
Hospices Civils de Lyon
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2016-10-04
- Primary Completion
- 2017-03-21
- Completion
- 2017-03-21
Countries
- France
Study Locations
More Related Trials
-
Immunogenicity of Two Dosages of Inactivated, Split-Virion Influenza Vaccine Given by an Alternate Route in the Elderly
NCT00296829 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Immunogenicity of Two Doses of H5N1 Influenza Vaccine in Elderly Subjects
NCT01766921 ·Status: COMPLETED ·Phase: PHASE2
-
The Immunogenicity and Safety of 2013-2014 Seasonal Trivalent Influenza Vaccine
NCT02269852 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Immunogenicity of One Dose of an Inactivated Trivalent Sub-unit Influenza Vaccine Administered to Non-elderly Adult and Elderly Subjects
NCT01357265 ·Status: COMPLETED ·Phase: PHASE2
-
H5N1 Vaccination With and Without AS03: Systems Biology Analysis
NCT01573312 ·Status: COMPLETED ·Phase: PHASE1
-
Inpatient Influenza Surveillance
NCT00419861 ·Status: COMPLETED
-
Safety and Immunogenicity Study of H3N2 M2SR Monovalent Influenza Vaccine in Healthy Volunteers
NCT02822105 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Immunogenicity Study of an Inactivated Influenza Vaccine (Whole Virion, Vero Cell Derived)
NCT00289510 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Safety and Immunogenicity of a Monovalent Inactivated Influenza H3N2 Variant (H3N2v) Vaccine in Adult and Elderly Populations
NCT01746082 ·Status: COMPLETED ·Phase: PHASE2
-
Dose, Safety, and Pathogenicity of a New Influenza A H3N2 Challenge Strain
NCT06613737 ·Status: COMPLETED ·Phase: NA
-
Study to Evaluate Immunogenicity, Safety and Tolerability of Adjuvanted and Non-Adjuvanted H2N3 Influenza Vaccines in Adults
NCT05875961 ·Status: COMPLETED ·Phase: PHASE1
-
Understanding Immunity to the Flu Vaccine in COVID-19 Patients
NCT04579588 ·Status: RECRUITING
-
Safety and Immunogenicity of Priming With Live Attenuated A/H7N9 Influenza Virus Vaccine Followed By Inactivated A/H7N9 Influenza Virus Vaccine With AS03 Adjuvant
NCT02957656 ·Status: COMPLETED ·Phase: PHASE1
-
The Effectiveness of Influenza Vaccine Among Health Care Workers in a Hospital Setting.
NCT00265161 ·Status: COMPLETED
-
H7N9 Vaccination With and Without AS03 and Unadjuvanted H3N2v Vaccination: Standard and Systems Biology Analyses
NCT02921997 ·Status: COMPLETED ·Phase: PHASE2
-
Influenza in People With Normal and Weakened Immune Systems
NCT00533182 ·Status: COMPLETED
-
Safety, Tolerability, Efficacy and Immunogenicity of an Influenza A Vaccine (FP-01.1) in Healthy Volunteers Following Virus Challenge
NCT02071329 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
"Quidel Reader Influenza A + B Test 510(k) and CLIA Waiver Field Study"
NCT01309568 ·Status: COMPLETED
-
Safety and Immunogenicity of Surface Antigen, Inactivated, Influenza Vaccine Using the Strain Composition 2009/2010 Recommended in Northern Hemisphere in Non-elderly Adult and in Elderly Subjects
NCT00918268 ·Status: COMPLETED ·Phase: PHASE2
-
Severe Influenza Cohort
NCT02392858 ·Status: COMPLETED ·Phase: NA
-
Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2007/2008) When Administered to Elderly Subjects
NCT00522236 ·Status: COMPLETED ·Phase: PHASE2
-
Influenza Vaccine Safety and Effectiveness in Healthcare Providers
NCT01282177 ·Status: COMPLETED
-
Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2007/2008) When Administered to NON Elderly AND Elderly Subjects
NCT00518726 ·Status: COMPLETED ·Phase: PHASE2
-
Does Seasonal Influenza Vaccination Affect the Incidence of pH1N1 Influenza?
NCT01001325 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Safety and Immunogenicity of an Inactivated Split-virion Influenza A(H1N1) Vaccine
NCT01201902 ·Status: COMPLETED ·Phase: PHASE3